Dr. Agarwal's Health Care (AGARWALEYE) Fundamentals 2026 — P/E 114.0x, Revenue Analysis | SniperIQ
Dr. Agarwal's Health Care (AGARWALEYE) is a India-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of ₹15,217 Crore, trading at ₹480.05 on the NSE. This SniperIQ fundamentals page covers Dr. Agarwal's Health Care's valuation (P/E 114.0x, P/B 7.5x), profitability (net margin 6.4%), revenue (₹2,080 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Dr. Agarwal's Health Care's market cap?
Dr. Agarwal's Health Care (AGARWALEYE) has a market capitalization of approximately ₹15,217 Crore, trading at ₹480.05 on the NSE. Market cap moves with the live share price.
What is Dr. Agarwal's Health Care's P/E ratio?
Dr. Agarwal's Health Care's trailing twelve-month P/E ratio is 114.0x, with a price-to-book (P/B) of 7.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Dr. Agarwal's Health Care?
Dr. Agarwal's Health Care runs a net profit margin of 6.4%, a gross margin of 34.2%, and an operating margin of 14.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Dr. Agarwal's Health Care generate?
Dr. Agarwal's Health Care reported revenue of ₹2,080 Crore for fiscal year 2026, with net income of ₹133 Crore and earnings per share (EPS) of 4.21. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Dr. Agarwal's Health Care pay a dividend?
Dr. Agarwal's Health Care does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Dr. Agarwal's Health Care financially healthy?
Dr. Agarwal's Health Care carries a debt-to-equity ratio of 0.53x and a current ratio of 1.24x, with a market beta of 0.75. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Dr. Agarwal's Health Care a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Dr. Agarwal's Health Care (AGARWALEYE) the key facts are: market cap ₹15,217 Crore, P/E 114.0x, revenue ₹2,080 Crore, 52-week range 401-568. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Dr. Agarwal's Health Care's full fundamentals live
Get Dr. Agarwal's Health Care's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.